PET/CT Can Help Detect Recurrent Thyroid Disease
Using PET/CT imaging can help clinicians detect recurrent thyroid disease among patients who have negative radioiodine scans.
PET/CT can accurately detect recurrent thyroid disease not demonstrated by radioiodine scans, according to a presentation that will be given in September at the Royal College of Radiologists Annual Scientific Meeting, which will be held in London, UK.
Researchers sought to determine the usefulness of PET/CT in detecting recurrent thyroid disease in patients who had a negative thyroid scan, but raised serum thyroglobulin levels. They performed a three-year retrospective study that involved 23 patients (average age, 54.2) who had thyroid cancer. All patients had a negative radioiodine scan and raised serum thyroglobulin levels.
All patients (11 males, 12 females) underwent PET/CT examination. The researchers found that for 12 patients (52.2 percent), the PET/CT detected recurrent thyroid lesions or distant metastases that had not been seen on radioiodine studies. There was also a statistically significant difference in the serum thyroglobulin levels between patients who were found to have positive lesions and those who did not have lesions.
The researchers concluded that the PET/CT imaging could accurately detect recurrent thyroid disease that was not found with radioiodine scans.
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.
